Global Arthroplasty Infections Treatment Market Size, Trends, and Analysis - Forecast to 2026 By Treatment Type (Oral Antibiotic Therapy, Intravenous Antibiotic Therapy, Antibiotic Spacer), By Infection Type (Hip Arthroplasty Infection, Knee Arthroplasty Infection, Shoulder Arthroplasty Infection, Others), By Distribution Sales (Institutional Sales, Hospitals, Ambulatory Surgical Centers, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia Pacific, MEA, and CSA), End-User Landscape, Company Market Share Analysis, and Competitor Analysis
Arthroplasty is a type of surgical procedure that is undertaken to restore the functional mechanisms of any joint. Arthroplasty strictly confines itself to resurfacing, repairing, replacing, or remodeling the ill-functioning joints. This orthopedic surgical procedure focuses on articular surfaces like the musculoskeletal joints. However, no medical procedure can escape the risk of post-surgery infections.
Surveys and databases show that a developed country like the United States report approximately 7 million people undergoing arthroplasty treatments, and the chances of getting exposed to infections or any other risks are always high. Studies say that infections can occur at any point during the post-surgery period, but reports have shown that 60 to 70 percent of patients face these infections within one or twoyearspost arthroplasty surgery.
Today, the ratio of the elderly population is relatively high in many countries across the world. Individuals above the age of 55 tend to experience age-related joint diseases, most commonly known as osteoarthritis. Surveys show that approximately 80% of the people older than 55 age report having osteoarthritis. Old age and osteoarthritis are some of the most common drivers for arthroplasty infection treatment. Also, in surgeries like arthroplasty, which involve joint repairing or joint replacement, come across or are exposed to artificial substances like metal or plastic that are implanted into the body. The human body has an abundance of bacteria in the gastrointestinal tract, which keeps the gut health in the balance, although these bacteria exposed to the external objects used during arthroplasty can cause severe infections, thus requiring arthroplasty infection treatment.
Besides the age factor and bacterial exposure, the patients with diabetes also tend to develop arthroplasty infections due to high blood sugar pressure. The rate of developing diabetes is comparatively more in individuals above the age of 50. The disorders like osteoarthritis are majorly reported in the elderly, making them more prone to developing infections post-surgery, thus accelerating demand for arthroplasty infection treatment. Studies have proved that individuals with immune deficiency, obesity, or those undergoing other treatments like chemotherapy, are also highly vulnerable to developing infections post joint repairing or joint replacement surgeries, thus boosting the growth in the arthroplasty infection treatment market.
Based on the treatment type, the arthroplasty infection treatment market is segmented into Oral Antibiotic Therapy, Intravenous Antibiotic Therapy, and Antibiotic Space. Amongst these, Intravenous (IV) Antibiotic therapy holds the largest share and is utilized the most to treat arthroplasty infections. Under technical terms, this particular therapy infuses or administers drugs and fluid directly through the veins.
Studies and research have shown that, in the case of arthroplasty infection treatments, oral antibiotic therapy has proven to be significantly ineffective in curing the infection. However, intravenous antibiotic therapy with its direct infusion of drugs to the veins has shown efficient results. Also, one more key feature facilitated by the IV antibiotic therapy is the ease and comfort to the patients. These therapies can be undertaken on an outpatient basis, where the patient feels safe and remains in a home setting. The feeling of a safe and familiar environment enables the patients with arthroplasty infection to heal faster compared to other treatment types. Many patients having phobias of consuming pills have a better, more accessible, quicker, and more effective alternative in the form of intravenous antibiotic therapy.
Based on the type of infection, the arthroplasty infection treatment market is classified intohip arthroplasty infection, knee arthroplasty infection, shoulder arthroplasty infection, and others. Knee arthroplasty infection is most commonly reported within various national arthroplasty infection treatment markets. Studies in the United States have shown that approximately 10.38% of knee-related arthroplasty surgeries are reported annually. These cases include a majority of the population certainly above the age of 70 to 80 years. These elderly individuals with these knee repair or replacement surgeries have higher chances of contracting infections, thus accelerating growth in this particular segment of knee arthroplasty infection within the market. Knee arthroplasty is also known to be an outcome of the last stage arthritis. Studies have shown that earlier, diagnosing knee arthroplasty infection was challenging and a complex process, but today, with increased innovations and newer techniques like ultrasonication has been playing an extended role in increasing the demand for knee arthroplasty infection.
Also, followed by knee arthroplasty infection, hips arthroplasty infection is predicted to witness fast growth within the arthroplasty infection treatment market. Surveys conducted in the United States show that approximately 5.26% of patients above the age of 70 to 80 years are reported annually with hip arthroplasty. Certainly, the increasing rate of hip arthroplasty increases the rate of individuals getting exposed to bacteria and reporting infections, thus accelerating growth in this segment.
Based on the type of distribution sales, the arthroplasty infection treatment market is segmented into institutional sales, hospitals, ambulatory surgical centers, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies. Hospitals are the most common and the dominant distribution channel in the arthroplasty infection treatment market. The rate of arthroplasty surgeries carried out in hospitals is more significant than in the rest of the healthcare centers. Thus, the subsequent arthroplasty infection treatments are carried out within the hospitals. Also, hospitals are huge setups with the availability of advanced techniques, diagnosing arthroplasty infections become quicker and more accessible, and treating these infections through hospitals sustains the assurance and reliability among the patients.
However, today with the increasing influence of intravenous antibiotic therapies, which can be performed at home care settings, the demand for online pharmacies is expected to grow at the fastest rate within the arthroplasty infection treatment market.
Based on regional segmentation, North America holds its dominance. Countries in the North American region like the United States have a high rate of arthroplasty surgeries carried out every year, which subsequently accelerates the growth in the arthroplasty infection treatment market. These countries also have a more significant amount of research and development investments to introduce new and effective techniques to diagnose infections and treat them.
However, the Asia-Pacific region is expected to witness fast growth in the market during the forecast period. Countries in the APAC region have a prominently larger elderly population, highly vulnerable to joint-related disorders and followed-up infections. The countries like China, Japan, and India, have been tremendously improving with respect to medical procedures and other healthcare facilities, with a high rate of FDIs and national level investments. These countries being in their developing phase, are witnessing an exponential increase in the number of practitioners and professional arthroplasty surgeons available to undertake arthroplasty infection treatments. Also, the influence of western countries is encouraging the Asia Pacific countries to explore the research and development sector, to bring in new techniques and procedures to carry out arthroplasty infection treatments.
Melinta Therapeutics, Inc., TenNor Therapeutics Ltd, Peptilogics, Arrevus, Nabriva Therapeutics plc, and Telephus Medical LLC, among others, are some of the most prominent industry players in the market.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The Global Arthroplasty Infections Treatment Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Arthroplasty Infections Treatment Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?